GenWay Biotech, Inc

As a leading protein and antibody solutions provider, GenWay has a proprietary technology platform and an international network to provide our clients with solutions and applications for antibodies, recombinant proteins, full-length cDNAs, cell lines and tissue samples. We specialize in recombinant proteins and domain-specific IgY (chicken) antibodies and their applications. GenWay’s technology and expertise make high quality protein antigens that enable production of high quality antibodies. To date, the Company has produced thousands of recombinant proteins and IgY antibodies.GenWay offers both products and services, from bioinformatics analysis to post-delivery technical support. The Company provides immunoaffinity protein partitioning (SepproTM) using IgY-microbeads (ProteomeLab-IgY) columns for highly specific separation of abundant plasma, serum, CSF or cellular proteins, which is a critical step in proteomic profiling and biomarker/drug target discovery. By applying tissue and antibody array technologies, GenWay also enables target validation and screening of important disease-related proteins and biomarkers.
To leverage the Company’s core competencies and resources, GenWay has formed many corporate partnerships and academic collaborations for product development and distribution. The Company welcomes potential partners and distributors to explore business relationships with GenWay.

Contact Details: 6777 Nancy Ridge Drive San Diego California 92121 United States of America Tel: (858)458-0866 Fax: (858)458-0833 Email: sales@genwaybio.com WWW: www.genwaybio.com/

Loading...

Press Releases on GenWay Biotech, Inc:
Sigma-Aldrich Acquires Seppro(R) Depletion Technology From GenWay Biotech	6th January, 2009	Sigma-Aldrich	ST. LOUIS, Mo., Jan. 6 /PRNewswire-FirstCall/ -- Sigma-Aldrich (Nasdaq: SIAL) has expanded its proteomics offerings with the acquisition of Seppro(R) affinity depletion technology and a library of

BioNews Results for GenWay Biotech, Inc:
Oncolytics Biotech(R) Inc. Announces Terms of Unit Offering	PR Newswire:  Nov 23 2009 12:45AM Matching: biotech inc
Oncolytics Biotech(R) Inc. Announces Unit Offering	PR Newswire:  Nov 23 2009 12:42AM Matching: biotech inc
News and FDA Updates for BD (NYSE:BDX), Soligenix, Inc. (OTC:SNGX)	Los Angeles Chronicle:  Nov 21 2009 8:33PM Matching: biotech inc
Updates for Geron (Nasdaq:GERN), NeoStem (NYSE:NBS), Non-Invasive Monitoring Systems (OTC:NIMU)	California Chronicle:  Nov 21 2009 8:29PM Matching: biotech inc
EFT Biotech Holdings To Make Institutional Presentation Throughout Europe	OfficialWire:  Nov 21 2009 6:20AM Matching: biotech inc
Promote your company here: BioNewsCast - Press Release Distribution	→View more GenWay Biotech, Inc news.

GenWay Biotech, Inc Patents:
US Patent No.	Title
6951742	Methods and vectors for generating antibodies in avian species and uses therefor
6780615	Production of recombinant monellin using methylotrophic yeast expression system

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 933 times since April 2007, the link to the organisation's website has been followed 119 times

Recent Search Terms used to find this page: | genway biotech inc. | genway distributors | GENWAY BIOTECH | applications of bioinformatics in IgY technology | biotech San Diego | genway distributors | genway igy | GENWAY | GenWay Biotech | .

Search for more companies in San Diego

Search for more companies in California

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for GenWay Biotech, Inc